The ESMO Academy Virtual Meeting 2021 programme is online!
Scientific Co-Chairs
- Viviane Hess, Basel, Switzerland
- Karin Jordan, Heidelberg, Germany
Main themes
Year after year, the ESMO Academy has offered delegates a comprehensive, thorough update on the key topics in medical oncology, including methodology and interpretation of clinical trials, standard of care and future perspectives in the main tumour types, pharmacokinetics and drug interactions.
- Colorectal Cancer
- Prostate Cancer
- Lung Cancer
- Breast Cancer
- Pharmacokinetics & Drug Interactions
- Methodology and interpretation of clinical trials
Learning objectives
- To learn/update participants about the current standard of care for the main malignancies and the supporting clinical trials.
- To learn about supportive care strategies: prophylaxis and therapy of tumour therapy induced side effects and tumour symptoms.
- To learn about the pharmacokinetics of systemic therapies for the management of cancer and the interactions of these drugs.
Accreditation
ESMO-MORA: The ESMO Academy 2021 has been accredited with 7 Cat. 1 ESMO-MORA points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possess the necessary skills and standards for the practice of medical oncology. See here for further details.
Disclaimer
All Speakers and Discussants are required to declare their interests, if any, and include a Declaration of Interest (DOI) slide at the start of their presentation(s).
The experts invited by ESMO as Discussants are selected on an individual basis to provide their own interpretation of the data and are not acting as ESMO spokespersons.
The ESMO recommendations on the clinical utility of new drugs are only presented in the ESMO Clinical Practice Guidelines and such recommendations represent the only official position of ESMO.
Webcasts
The Congress webcasts will include all the sessions of the official programme, where speaker permission is granted, and will be available on the page dedicated to meeting resources on this website and OncologyPRO for ESMO members.
